Global Bionematicides Industry

Global Bionematicides Industry

  • September 2020 •
  • 152 pages •
  • Report ID: 5960579 •
  • Format: PDF
Global Bionematicides Market to Reach $685 Million by 2027

Amid the COVID-19 crisis, the global market for Bionematicides estimated at US$238.3 Million in the year 2020, is projected to reach a revised size of US$685 Million by 2027, growing at a CAGR of 16.3% over the analysis period 2020-2027. Cereals & Grains, one of the segments analyzed in the report, is projected to record a 16.6% CAGR and reach US$171.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oilseeds & Pulses segment is readjusted to a revised 16.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $64.2 Million, While China is Forecast to Grow at 21% CAGR

The Bionematicides market in the U.S. is estimated at US$64.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$158.6 Million by the year 2027 trailing a CAGR of 21% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Fruits & Vegetables Segment to Record 16.6% CAGR

In the global Fruits & Vegetables segment, USA, Canada, Japan, China and Europe will drive the 15.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$50 Million in the year 2020 will reach a projected size of US$138.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$106 Million by the year 2027, while Latin America will expand at a 18.4% CAGR through the analysis period. We bring years of research experience to this 9th edition of our report. The 152-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • Bayer CropScience AG
  • Beijing Ecoman Biotech Co., Ltd.
  • Certis USA LLC
  • Dow AgroSciences LLC
  • LAM International
  • Marrone Bio Innovations, Inc.
  • Monsanto Company
  • Syngenta AG
  • Valent BioSciences Corporation